We are live on ! Find out more
TCMP

Thrive Capital Management (Pennsylvania) Portfolio holdings

AUM $530M
1-Year Est. Return 22.41%
This Fund
S&P 500
This Quarter Est. Return
-1%
1 Year Est. Return
+22.41%
3 Year Est. Return
+58.21%
5 Year Est. Return
+53.58%
10 Year Est. Return
–
AUM
$135M
AUM Growth
+$6.85M
Cap. Flow
+$8.62M
Cap. Flow %
6.36%
Top 10 Hldgs %
40.04%
Holding
111
New
2
Increased
45
Reduced
53
Closed
4

Top Buys

Rank Stock Value
1
SPYG icon
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
+$1.8M
2
AOM icon
iShares Core Moderate Allocation ETF
AOM
+$1.15M
3
SHYG icon
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
+$1M
4
DGRO icon
iShares Core Dividend Growth ETF
DGRO
+$928K
5
GOVT icon
iShares US Treasury Bond ETF
GOVT
+$896K

Top Sells

Rank Stock Value
1
NEAR icon
iShares Short Maturity Bond ETF
NEAR
+$796K
2
ICSH icon
iShares Ultra Short Duration Bond Active ETF
ICSH
+$489K
3
WST icon
West Pharmaceutical
WST
+$345K
4
VNLA icon
Janus Henderson Short Duration Income ETF
VNLA
+$300K
5
NEE icon
NextEra Energy
NEE
+$254K

Sector Composition

Rank Sector Weight
1 Technology 8.58%
2 Healthcare 6.37%
3 Consumer Staples 3.73%
4 Communication Services 2.76%
5 Financials 2.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EFG icon
101
iShares MSCI EAFE Growth ETF
EFG
$17.3B
$227K 0.17%
2,134
-775
-27% -$85.3K
FIS icon
102
Fidelity National Information Services
FIS
$22.1B
$225K 0.17%
1,846
-47
-2% -$6.3K
V icon
103
Visa
V
$677B
$225K 0.17%
+1,011
New +$237K
EBND icon
104
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.29B
$217K 0.16%
8,569
-1,338
-14% -$34.8K
PDBC icon
105
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.42B
$217K 0.16%
10,315
-4,119
-29% -$82.6K
BSV icon
106
Vanguard Short-Term Bond ETF
BSV
$45.6B
$216K 0.16%
2,640
-74
-3% -$6.08K
IVW icon
107
iShares S&P 500 Growth ETF
IVW
$77.6B
$203K 0.15%
2,744
-24
-0.9% -$1.83K
NEE icon
108
NextEra Energy
NEE
$177B
– –
-3,468
Closed -$254K
PFE icon
109
Pfizer
PFE
$153B
– –
-5,518
Closed -$216K
WST icon
110
West Pharmaceutical
WST
$24.9B
– –
-962
Closed -$345K
XOM icon
111
ExxonMobil
XOM
$634B
– –
-3,458
Closed -$218K
1 2 3 4
5

Similar funds

UFF
USA Financial Formulas Ada, Michigan $531M AUM 28.6% 1-Year Est. Return
TM
Taproot Management New York $530M AUM
KI
Kapitalo Investimentos Sao Paulo, Brazil $531M AUM 25.72% 1-Year Est. Return
PWS
Proactive Wealth Strategies Marietta, Georgia $532M AUM 21.29% 1-Year Est. Return
SLC
Second Line Capital Metairie, Louisiana $528M AUM 16.68% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
LIM
Lathrop Investment Management Little Rock, Arkansas $534M AUM 22.94% 1-Year Est. Return
DA
Drake & Associates Waukesha, Wisconsin $525M AUM 14.04% 1-Year Est. Return

Thrive Capital Management (Pennsylvania)'s Q3 2021 Portfolio in Review

As of Q3 2021, Thrive Capital Management (Pennsylvania) held 111 positions worth $135M, up 5.3% from $129M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Thrive Capital Management (Pennsylvania) deployed $8.62M of net new capital in Q3 2021, opening 2 new positions and adding to 45 existing holdings. Its largest new stake was Invesco S&P 500 Low Volatility ETF: 3,924 shares worth $239K.

By sector, the portfolio is most concentrated in Technology at 8.6% of assets, down from 8.7% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was iShares Short Maturity Bond ETF, an estimated $796K trimmed.

  • Thrive Capital Management (Pennsylvania)'s largest Q3 2021 buy was Invesco S&P 500 Low Volatility ETF: 3,924 shares worth $239K.
  • Thrive Capital Management (Pennsylvania) added most to State Street SPDR Portfolio S&P 500 Growth ETF in Q3 2021, an estimated $1.8M increase.
  • Thrive Capital Management (Pennsylvania)'s biggest Q3 2021 reduction was iShares Short Maturity Bond ETF, cutting an estimated $796K.
  • Thrive Capital Management (Pennsylvania) fully exited West Pharmaceutical in Q3 2021, selling an estimated $345K.
  • Thrive Capital Management (Pennsylvania)'s ten largest holdings make up 40% of its $135M portfolio in Q3 2021.
  • Thrive Capital Management (Pennsylvania) opened 2 new positions and closed 4 in Q3 2021.
  • Thrive Capital Management (Pennsylvania)'s portfolio value rose 5.3% quarter-over-quarter to $135M.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q3 2021, filed 12 Nov 2021.